"Blood-Retinal Barrier" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specialized transport barrier, in the EYE, formed by the retinal pigment EPITHELIUM, and the ENDOTHELIUM of the BLOOD VESSELS of the RETINA. TIGHT JUNCTIONS joining adjacent cells keep the barrier between cells continuous.
| Descriptor ID |
D001813
|
| MeSH Number(s) |
A07.040 A09.371.729.055
|
| Concept/Terms |
Blood-Retinal Barrier- Blood-Retinal Barrier
- Barrier, Blood-Retinal
- Barriers, Blood-Retinal
- Blood Retinal Barrier
- Blood-Retinal Barriers
- Retinal-Blood Barrier
- Barrier, Retinal-Blood
- Barriers, Retinal-Blood
- Retinal Blood Barrier
- Retinal-Blood Barriers
|
Below are MeSH descriptors whose meaning is more general than "Blood-Retinal Barrier".
Below are MeSH descriptors whose meaning is more specific than "Blood-Retinal Barrier".
This graph shows the total number of publications written about "Blood-Retinal Barrier" by people in this website by year, and whether "Blood-Retinal Barrier" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood-Retinal Barrier" by people in Profiles.
-
Yan Z, Wang C, Meng Z, Gan L, Guo R, Liu J, Bond Lau W, Xie D, Zhao J, Lopez BL, Christopher TA, Naik UP, Ma X, Wang Y. C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood-Retinal Barrier Tight Junctions. Cells. 2022 02 23; 11(5).
-
Rao P, Robinson J, Yonekawa Y, Thomas BJ, Drenser KA, Trese MT, Capone A. WIDE-FIELD IMAGING OF NONEXUDATIVE AND EXUDATIVE CONGENITAL X-LINKED RETINOSCHISIS. Retina. 2016 Jun; 36(6):1093-100.
-
Pitcher JD, Witkin AJ, DeCroos FC, Ho AC. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Br J Ophthalmol. 2015 Jun; 99(6):848-52.